BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21443518)

  • 1. Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum.
    Jortzik E; Mailu BM; Preuss J; Fischer M; Bode L; Rahlfs S; Becker K
    Biochem J; 2011 Jun; 436(3):641-50. PubMed ID: 21443518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies.
    Haeussler K; Berneburg I; Jortzik E; Hahn J; Rahbari M; Schulz N; Preuss J; Zapol'skii VA; Bode L; Pinkerton AB; Kaufmann DE; Rahlfs S; Becker K
    Malar J; 2019 Jan; 18(1):22. PubMed ID: 30683097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target.
    Allen SM; Lim EE; Jortzik E; Preuss J; Chua HH; MacRae JI; Rahlfs S; Haeussler K; Downton MT; McConville MJ; Becker K; Ralph SA
    FEBS J; 2015 Oct; 282(19):3808-23. PubMed ID: 26198663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphate metabolism in Plasmodium falciparum.
    Preuss J; Jortzik E; Becker K
    IUBMB Life; 2012 Jul; 64(7):603-11. PubMed ID: 22639416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase.
    Berneburg I; Peddibhotla S; Heimsch KC; Haeussler K; Maloney P; Gosalia P; Preuss J; Rahbari M; Skorokhod O; Valente E; Ulliers D; Simula LF; Buchholz K; Hedrick MP; Hershberger P; Chung TDY; Jackson MR; Schwarzer E; Rahlfs S; Bode L; Becker K; Pinkerton AB
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0210921. PubMed ID: 35266827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening for small-molecule inhibitors of plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase.
    Preuss J; Hedrick M; Sergienko E; Pinkerton A; Mangravita-Novo A; Smith L; Marx C; Fischer E; Jortzik E; Rahlfs S; Becker K; Bode L
    J Biomol Screen; 2012 Jul; 17(6):738-51. PubMed ID: 22496096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.
    Preuss J; Maloney P; Peddibhotla S; Hedrick MP; Hershberger P; Gosalia P; Milewski M; Li YL; Sugarman E; Hood B; Suyama E; Nguyen K; Vasile S; Sergienko E; Mangravita-Novo A; Vicchiarelli M; McAnally D; Smith LH; Roth GP; Diwan J; Chung TD; Jortzik E; Rahlfs S; Becker K; Pinkerton AB; Bode L
    J Med Chem; 2012 Aug; 55(16):7262-72. PubMed ID: 22813531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient silencing of Plasmodium falciparum bifunctional glucose-6-phosphate dehydrogenase- 6-phosphogluconolactonase.
    Crooke A; Diez A; Mason PJ; Bautista JM
    FEBS J; 2006 Apr; 273(7):1537-46. PubMed ID: 16689939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First homology model of Plasmodium falciparum glucose-6-phosphate dehydrogenase: Discovery of selective substrate analog-based inhibitors as novel antimalarial agents.
    Alencar N; Sola I; Linares M; Juárez-Jiménez J; Pont C; Viayna A; Vílchez D; Sampedro C; Abad P; Pérez-Benavente S; Lameira J; Bautista JM; Muñoz-Torrero D; Luque FJ
    Eur J Med Chem; 2018 Feb; 146():108-122. PubMed ID: 29407943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
    Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
    Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian children.
    Sodeinde O; Clarke JL; Vulliamy TJ; Luzzatto L; Mason PJ
    Br J Haematol; 2003 Aug; 122(4):662-8. PubMed ID: 12899722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites.
    Clarke JL; Scopes DA; Sodeinde O; Mason PJ
    Eur J Biochem; 2001 Apr; 268(7):2013-9. PubMed ID: 11277923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways for the reduction of oxidized glutathione in the Plasmodium falciparum-infected erythrocyte: can parasite enzymes replace host red cell glucose-6-phosphate dehydrogenase?
    Roth EF; Schulman S; Vanderberg J; Olson J
    Blood; 1986 Mar; 67(3):827-30. PubMed ID: 3511989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities.
    Mehta M; Sonawat HM; Sharma S
    J Vector Borne Dis; 2006 Sep; 43(3):95-103. PubMed ID: 17024857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic properties from bass liver 6-phosphogluconolactonase.
    Medina-Puerta MM; Gallego-Iniesta M; Garrido-Pertierra A
    Biochem Int; 1988 Mar; 16(3):571-7. PubMed ID: 3382425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
    Beutler E; Duparc S;
    Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
    Malar J; 2015 May; 14():218. PubMed ID: 26017006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphate dehydrogenase of malaria parasite Plasmodium falciparum.
    Yoshida A; Roth EF
    Blood; 1987 May; 69(5):1528-30. PubMed ID: 3552078
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.